|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5560 EUR | -0.36% |
|
-10.19% | -63.87% |
| 07-13 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 07-10 | AB Science streamlines its portfolio and refocuses on two molecules |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.74 | 0.898 | 0.895 |
| Spread/Res. | -25.00% | -38.20% | -37.99% |
| Spread/Supp. | +18.59% | +43.04% | +20.92% |
| Support | 0.468 | 0.388 | 0.459 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AB Stock
- Charts AB Science
Select your edition
All financial news and data tailored to specific country editions
